MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dayton, J. S.
Right arrow Articles by Mitchell, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dayton, J. S.
Right arrow Articles by Mitchell, B. S.

Comparison of the effects of mizoribine with those of azathioprine, 6- mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism

JS Dayton, LA Turka, CB Thompson and BS Mitchell

Department of Pharmacology, University of Michigan, Ann Arbor.

The immunosuppressive drug mizoribine has been demonstrated to inhibit T lymphocyte proliferation by depleting these cells of guanine ribonucleotides as a consequence of inhibiting the enzyme inosine monophosphate (IMP) dehydrogenase. Because the immunosuppressive agents azathioprine and 6-mercaptopurine (6MP) are both converted to the IMP analog 6-thio-IMP, we postulated that these drugs might inhibit T cell activation and/or proliferation by a similar mechanism. Incubation of isolated peripheral blood T cells with either mizoribine or the selective IMP dehydrogenase inhibitor mycophenolic acid caused a dose- dependent inhibition of T cell proliferation, which was reversible with the addition of 50 microM guanosine to replete guanine ribonucleotide pools. In contrast, guanosine exacerbated the inhibition of proliferation induced by azathioprine and restored proliferation at IC50 concentrations of 6MP by only 10%. Complete restoration of proliferation in the presence of 6MP, but not azathioprine, was achieved with the addition of adenine. The inhibitory effects of azathioprine, as well as those of mizoribine, 6MP, and mycophenolic acid, were identical in cells stimulated with antibody to the T cell receptor and in cells stimulated with phorbol ester and ionomycin. We conclude from these studies that mizoribine selectively inhibits guanine ribonucleotide formation in purified T cells, whereas the effect of 6MP appears to be more dependent on adenine ribonucleotide depletion. Azathioprine, on the other hand, inhibits proliferation by a mechanism independent of purine ribonucleotide depletion. None of these agents inhibits T cell proliferation by interfering with signal transduction mediated by the T cell receptor. Inhibition of guanine ribonucleotide biosynthesis appears to be a novel and perhaps more selective mechanism of inhibiting T cell proliferative responses after T cell activation.

Volume 41, Issue 4, pp. 671-676, 04/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
GeneticsHome page
H. Long, S. Cameron, L. Yu, and Y. Rao
De Novo GMP Synthesis Is Required for Axon Guidance in Drosophila
Genetics, March 1, 2006; 172(3): 1633 - 1642.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
Y.-M. Ku, M. McCartan, and D. Collier
Clinical Pharmacokinetic and Pharmacodynamic Monitoring for Mycophenolate Mofetil
Journal of Pharmacy Practice, December 1, 2005; 18(6): 422 - 431.
[Abstract] [PDF]


Home page
LupusHome page
A C Allison
Mechanisms of action of mycophenolate mofetil
Lupus, March 1, 2005; 14(3_suppl): s2 - s8.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. W. Thomas, G. M. Myhre, R. Tschumper, R. Sreekumar, D. Jelinek, D. J. McKean, J. J. Lipsky, W. J. Sandborn, and L. J. Egan
Selective Inhibition of Inflammatory Gene Expression in Activated T Lymphocytes: A Mechanism of Immune Suppression by Thiopurines
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 537 - 545.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A. Allison
Mechanisms of action of mycophenolate mofetil
Lupus, January 1, 2005; 14(1_suppl): s2 - s8.
[Abstract] [PDF]


Home page
J Clin PharmacolHome page
M. A. Kamal and W. J. Jusko
Interactions of Prednisolone and Other Immunosuppressants Used in Dual Treatment of Systemic Lupus Erythematosus in Lymphocyte Proliferation Assays
J. Clin. Pharmacol., September 1, 2004; 44(9): 1034 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
T. M. Sievers
New Antiproliferative Immunosuppressive Agents
Journal of Pharmacy Practice, December 1, 2003; 16(6): 401 - 413.
[Abstract] [PDF]


Home page
Mol. Cell. Biol.Home page
J. J. Gu, A. K. Tolin, J. Jain, H. Huang, L. Santiago, and B. S. Mitchell
Targeted Disruption of the Inosine 5'-Monophosphate Dehydrogenase Type I Gene in Mice
Mol. Cell. Biol., September 15, 2003; 23(18): 6702 - 6712.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Quemeneur, L.-M. Gerland, M. Flacher, M. Ffrench, J.-P. Revillard, and L. Genestier
Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides
J. Immunol., May 15, 2003; 170(10): 4986 - 4995.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Quemeneur, M. Flacher, L.-M. Gerland, M. Ffrench, J.-P. Revillard, and N. Bonnefoy-Berard
Mycophenolic Acid Inhibits IL-2-Dependent T Cell Proliferation, But Not IL-2-Dependent Survival and Sensitization to Apoptosis
J. Immunol., September 1, 2002; 169(5): 2747 - 2755.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Korn, K. Toyka, H.-P. Hartung, and S. Jung
Suppression of experimental autoimmune neuritis by leflunomide
Brain, September 1, 2001; 124(9): 1791 - 1802.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Korecka, D. Nikolic, R. B. van Breemen, and L. M. Shaw
The Apparent Inhibition of Inosine Monophosphate Dehydrogenase by Mycophenolic Acid Glucuronide Is Attributable to the Presence of Trace Quantities of Mycophenolic Acid
Clin. Chem., July 1, 1999; 45(7): 1047 - 1050.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Laliberte, A. Yee, Y. Xiong, and B. S. Mitchell
Effects of Guanine Nucleotide Depletion on Cell Cycle Progression in Human T Lymphocytes
Blood, April 15, 1998; 91(8): 2896 - 2904.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Zimmermann, K. L. Wright, J. P.-Y. Ting, and B. S. Mitchell
Regulation of Inosine-5'-monophosphate Dehydrogenase Type II Gene Expression in Human T Cells. ROLE FOR A NOVEL 5' PALINDROMIC OCTAMER SEQUENCE
J. Biol. Chem., September 5, 1997; 272(36): 22913 - 22923.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Hortelano and L. Bosca
6-Mercaptopurine Decreases the Bcl-2/Bax Ratio and Induces Apoptosis in Activated Splenic B Lymphocytes
Mol. Pharmacol., March 1, 1997; 51(3): 414 - 421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Gu, J. Spychala, and B. S. Mitchell
Regulation of the Human Inosine Monophosphate Dehydrogenase Type I Gene. UTILIZATION OF ALTERNATIVE PROMOTERS
J. Biol. Chem., February 14, 1997; 272(7): 4458 - 4466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Fairbanks, M. Bofill, K. Ruckemann, and H. A. Simmonds
Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans
J. Biol. Chem., December 15, 1995; 270(50): 29682 - 29689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Zimmermann, J. Spychala, and B. S. Mitchell
Characterization of the Human Inosine-5`-monophosphate Dehydrogenase Type II Gene
J. Biol. Chem., March 24, 1995; 270(12): 6808 - 6814.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics